Epigenetic silencing of tumor suppressor candidate 3 confers adverse prognosis in early colorectal cancer

Colorectal cancer (CRC) is a biologically and clinically heterogeneous disease. Even though many recurrent genomic alterations have been identified that may characterize distinct subgroups, their biological impact and clinical significance as prognostic indicators remain to be defined. The tumor sup...

Descripción completa

Detalles Bibliográficos
Autores principales: Burgermeister, Elke, Höde, Patrick, Betge, Johannes, Gutting, Tobias, Merkel, Andreas, Wu, Wen, Tänzer, Marc, Mossner, Maximilian, Nowak, Daniel, Magdeburg, Julia, Rückert, Felix, Sticht, Carsten, Breitkopf-Heinlein, Katja, Schulte, Nadine, Härtel, Nicolai, Belle, Sebastian, Post, Stefan, Gaiser, Timo, Heppner, Barbara Ingold, Behrens, Hans-Michael, Röcken, Christoph, Ebert, Matthias P.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Priority Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689568/
https://www.ncbi.nlm.nih.gov/pubmed/29156678
http://dx.doi.org/10.18632/oncotarget.20950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689568/
https://www.ncbi.nlm.nih.gov/pubmed/29156678
http://dx.doi.org/10.18632/oncotarget.20950

Ejemplares similares